Author:
Wasserman Todd H.,Stetz JoAnn,Phillips Theodore L.
Reference15 articles.
1. Committee on Radiation Oncology Studies Research Plan: Radiation Sensitizers, Cancer 37:2062 (1976).
2. T.L. Phillips, T.H. Wasserman, R.J. Johnson, C.J. Gomer, G.A. Lawrence, M.L. Levine, W. Sadee, J.S. Penta and D.J. Rubin, The Hypoxic cell sensitizer programme in the United States, Br. J. Cancer 37: Suppl.III, 276 (1978).
3. P. Rubin, R.B. Cowan and D.J. Rubin, The radiation oncology research program, B. Radiosensitizers/radioprotectors working group, Int.J.Radiation Oncology Biol.Phys. 5:651(1979).
4. J.D. Chapman, Current concepts in cancer: Hypoxic sensitizers-implications for radiation therapy, New.Eng.J.Med. 301:1429 (1979).
5. T.H. Wasserman, T.L. Phillips, R.J. Johnson, C.J. Gomer, G.A. Lawrence, W. Sadee, R.A. Marques, V.A. Levin and G. VanRaalte, Initial United States clinical and pharmacologic evaluation of misonidazole (RO-07–0582) an hypoxic cell radio sensitizer, Int.J.Radiation Oncology Biol. Phys. 5:775 (1979).